{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/06/29/3319292/0/en/Silo-Pharma-Advances-SPC-15-PTSD-Therapeutic-with-Drug-Device-Robustness-Study-Ahead-of-Planned-FDA-Type-C-Meeting-Request.html", "message": "News view counter 821248 successfully enlarged"}